Loading company
Immunovant, Inc.
IMVT · Nasdaq · ·
Next earnings: November 9, 2026
$33.450.0%Sep 29 close
- 1M
- -18.8%
- 6M
- +42.0%
- 1Y
- +107.5%
- 5Y
- +272.9%
IMVT · Nasdaq · ·
Next earnings: November 9, 2026
$33.450.0%Sep 29 close
Immunovant, Inc. is scheduled to report next on November 9, 2026. The date comes from Nasdaq’s earnings calendar, and companies sometimes move it.
The quarter ending June 30, 2026, against the same quarter a year earlier.
| Measure | 3 months toJun 30, 2026 | 3 months toJun 30, 2025 | Change |
|---|---|---|---|
| Profit | -$153.2M | -$120.6M | -27.04% |
| Profit per share | -$0.75 | -$0.71 | -5.63% |
| Free Cash Flow | -$95.1M | -$110.8M | +14.23% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Immunovant, Inc. has no earnings call transcript available.
Releases land after the close or before the open, so the move is the session that follows.
Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases and is a majority-owned subsidiary of Roivant (Nasdaq: ROIV). As a trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet the complex and variable needs of people with autoimmune diseases. For additional information on the Company, please visit immunovant.com. Investor Conference Call Information Roivant will host a live conference call and webcast at 8:00 a.m. ET on Thursday, August 6, 2026. To access the conference call by phone, please register online using this Registration link. The presentation and webcast details will also be available under “Events & Presentations” in the Investors section of the Immunovant website at https://www.immunovant.com/investors/news-events/ir-calendar. The archived webcast will be available on Immunovant’s website after the conference call.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Immunovant, Inc.’s Item 2.02 8-K filed August 6, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.